OssiFi ossifi.com


Public lists: Pharma Startups (6570)

OssiFi is focused on developing the next generation of bone graft substitutes to stimulate fracture repair, reduce the rate of delayed or non-unions and accelerate return to function. OssiFi utilizes a small molecule to modulate bone growth through Sclerostin inhibition. Its carrier matrix is intended to combine excellent handling characteristics, ideal release kinetics and cellular in-growth capabilities with demonstrated biocompatibility.

OssiFi is focused on developing the next generation of bone graft substitutes to stimulate fracture repair, reduce the rate of delayed or non-unions and accelerate return to function. OssiFi utilizes a small molecule to modulate bone growth through S...Show all

Company (Alive / Active)

Phone: 913-660-0637

Fax:

2002 West 39th Ave

Kansas City, 66103
Kansas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
OssiFi $2M Nov 6, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related OssiFi Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Undisclosed InvestorsOtherUnattributed - III, Unattributed - II, Unattributed
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of altering bone growth by administration of sost or wise antagonist or agonist Mar 12, 2013 Nov 04, 2014 Patent
Boldline compounds for promoting bone growth Apr 25, 2012 Jun 11, 2013 Patent
Methods of altering bone growth by administration of sost or wise antagonist or agonist Oct 02, 2014 Application